Therefore, the objective of this study is to create a dual-receptor-targeted peptide heterodimer probe that simultaneously targets SSTR2 and FAP, with the expectation of improving tumor detection sensitivity and extending tracer uptake and retention time. Here, FAP is linked to neoplasm.